Publications by authors named "Matthew Yan"

Article Synopsis
  • Advances in mobile tech and AI have led to a rise in dermatology apps for consumers, but evidence supporting their effectiveness is limited.
  • A study analyzed 909 AI dermatology apps, narrowing it down to 41 after reviewing their purpose, evidence, regulatory status, and data privacy.
  • Findings showed that none of the apps were FDA-approved, and most lacked clinician input and transparency, raising concerns about their reliability and safety for consumers.
View Article and Find Full Text PDF

Background: Regulatory aspects of transfusion medicine add complexity in blinded transfusion trials when considering various electronic record keeping software and blood administration processes. The aim of this study is to explore strategies when blinding transfusion components and products in paper and electronic medical records.

Methods: Surveys were collected and interviews were conducted for 18 sites across various jurisdictions in North America to determine solutions applied in previous transfusion randomized control trials.

View Article and Find Full Text PDF

Background: Femoral neck stress fractures are rare fractures traditionally found in athletes and military personnel. There is limited literature on return to activity.

Objectives: To report return to activity rates and times, and long-term outcomes for femoral neck stress fractures reported in the literature.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined the safety of giving group O uncrossmatched red blood cells (RBC) and low titer group O whole blood (LTOWB) to non-group O trauma patients during resuscitation.
  • Patients were classified into three groups based on their transfusion history, and the impact of receiving non-O RBCs on mortality rates was analyzed.
  • Results indicated that while non-group O patients receiving only group O RBCs had higher mortality at 6 hours, those receiving a mix of group O and non-O RBCs did not show increased mortality at later time points, suggesting the practice is safe.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the impact of serologic reactivity of unidentified specificity (SRUS) during pregnancy on the risk of hemolytic disease of the fetus and newborn (HDFN).
  • Over an 11-year period, data from 284 pregnancies with SRUS were analyzed, revealing that most cases of SRUS were not associated with HDFN, even in the presence of ABO incompatibility or other identifiable antibody reactions.
  • The findings suggest that while SRUS alone does not indicate HDFN risk, it can occasionally precede clinically significant antibodies linked to HDFN.
View Article and Find Full Text PDF

Background: The Jr blood group system includes a single, high-prevalence antigen, Jr , encoded by the ABCG2 gene. The impact of anti-Jr in pregnancy is variable, ranging from no clinical effect to severe anemia including some fetal deaths. Case reports have postulated that anti-Jr mediated fetal anemia is poorly hemolytic, suggesting other mechanisms of anemia may be involved.

View Article and Find Full Text PDF

Background: Canadian hematology residents are required to demonstrate competencies in transfusion medicine by the end of their 2-year training. Prior evaluation of final year trainees revealed significant variation in knowledge. To address the lack of standardization in serology teaching, an online educational immunohematology resource was created and evaluated.

View Article and Find Full Text PDF

Background: The demand for rare blood is expected to increase in Canada as its population continues to expand through immigration from diverse regions of the world.

Material And Methods: This paper outlines a national approach to providing rare red cells for patients through the Rare Blood Program of Canadian Blood Services (CBS). Data detailing the rare red cell requests and inventory managed by CBS' Rare Blood Program is provided.

View Article and Find Full Text PDF

Background: Early damage control resuscitation and massive transfusion (MT) protocol activations improve outcomes in trauma patients with hemorrhagic shock, where scores to guide MT prediction are used including: the Assessment of Blood Consumption (ABC), Shock Index (SI), and Revised Assessment of Bleeding and Transfusion (RABT) scores. Our aim was to validate the RABT score in patients from two level I trauma centers in Canada.

Methods: A retrospective review of adult patients meeting trauma team activation criteria receiving >1 unit of red blood cells (RBCs) within 24 h of admission, from 2015 to 2020, was conducted.

View Article and Find Full Text PDF

Background And Objectives: The coronavirus disease 2019 (COVID-19) pandemic raised concerns about the vulnerability of platelet supply and the uncertain impact of the resumption of elective surgery on utilization. We report the impact of COVID-19 on platelet supply and utilization across a large, integrated healthcare system in the Canadian province of British Columbia (BC).

Materials And Methods: Historical platelet use in BC by indication was compiled for fiscal year 2010/2011-2019/2020.

View Article and Find Full Text PDF

Despite being FDA-approved for COVID-19, the clinical efficacy of remdesivir (Veklury) remains contentious. We previously pointed out pharmacokinetic, pharmacodynamic and toxicology reasons for why its parent nucleoside GS-441524, is better suited for COVID-19 treatment. Here, we assess the oral bioavailability of GS-441524 in beagle dogs and show that plasma concentrations ~24-fold higher than the EC against SARS-CoV-2 are easily and safely sustained.

View Article and Find Full Text PDF

Background: This study investigated the effect on mortality of transfusing ABO-incompatible plasma from all sources during trauma resuscitation.

Methods: Demographic, transfusion, and survival data were retrospectively extracted on civilian trauma patients. Patients were divided by receipt of any quantity of ABO-incompatible plasma from any blood product (incompatible group) or receipt of solely ABO-compatible plasma (compatible group).

View Article and Find Full Text PDF

Glycolysis inhibition remains aspirational in cancer therapy. We recently described a promising phosphonate inhibitor of enolase for cancers harboring homozygous deletions of . Here, we describe the application of a nitroheterocycle phosphonoamidate pro-drug pair to capitalize on tumor hypoxia.

View Article and Find Full Text PDF

Chemotherapy is central to oncology, perceived to operate only on prolific cancerous tissue. Yet, many non-neoplastic tissues are more prolific compared with typical tumors. Chemotherapies achieve sufficient therapeutic windows to exert antineoplastic activity because they are prodrugs that are bioactivated in cancer-specific environments.

View Article and Find Full Text PDF

Background: Alloimmunisation and haemolytic transfusion reactions (HTRs) can occur in patients with sickle cell disease (SCD) despite providing phenotype-matched red blood cell (RBC) transfusions. Variant RBC antigen gene alleles/polymorphisms can lead to discrepancies in serological phenotyping. We evaluated differences between RBC antigen genotyping and phenotyping methods and retrospectively assessed if partial antigen expression may lead to increased risk of alloimmunisation and HTRs in SCD patients at a tertiary centre in Canada.

View Article and Find Full Text PDF

Background: West Nile Virus (WNV) is a member of the Japanese Encephalitis (JE) serocomplex within the Flaviviridae family. We report four whole blood donors and one plasma donor with WNV nucleic acid test (NAT)-reactive donations between September 2018 and November 2019, following recent Japanese Encephalitis virus (JEV) vaccination.

Case Series: Cases 1 and 4 had reactive WNV NAT donations 1 day after receiving the JEV vaccine.

View Article and Find Full Text PDF

Homogeneous populations of mature differentiated primary cell types can display variable responsiveness to extracellular stimuli, although little is known about the underlying mechanisms that govern such heterogeneity at the level of gene expression. In this article, we show that morphologically homogenous human endothelial cells exhibit heterogeneous expression of VCAM1 after TNF-α stimulation. Variability in VCAM1 expression was not due to stochasticity of intracellular signal transduction but rather to preexisting established heterogeneous states of promoter DNA methylation that were generationally conserved through mitosis.

View Article and Find Full Text PDF

Introduction: Decreases in trainees' working hours, coupled with evidence of worse outcomes when hip arthroscopies are performed by inexperienced surgeons, mandate an additional means of training. Though virtual reality simulation has been adopted by other surgical specialities, its slow uptake in arthroscopic training is due to a lack of evidence as to its benefits. These benefits can be demonstrated through learning curves associated with simulator training-with practice reflecting increases in validated performance metrics.

View Article and Find Full Text PDF

Background: Canadian hematology trainees are expected to attain clinical knowledge in the subject of red blood cell and platelet antigen systems and the principles of transfusion medicine. However, the relative degree of expertise required in blood bank serology is not well defined.

Study Design And Methods: A modified Delphi approach involving 10 Canadian hematology program directors was utilized to identify 12 relevant topics in immunohematology.

View Article and Find Full Text PDF

The transfusion chain is susceptible to error at every step. Accurate patient registration is a key first step that links a patient with their historical medical profile, yet patient registration is marked by its own challenges. Registration errors are deviations from standard operating procedures that occur during the process of patient registration.

View Article and Find Full Text PDF